Alternative treatments for focal and segmental glomerular sclerosis

C. Ponticelli, P. Passerini

Research output: Contribution to journalArticle

Abstract

Corticosteroids represent the first therapeutic approach for patients with focal and segmantal glomerulosclerosis. What to do in patients who do not respond to corticostetoids is still uncertain. Cytotoxic agents have been tried. The results are usually poor when these drugs are given for short periods but almost half of patients may enter remission ir treatment is prolonged. Some decrease in proteinuria may be obtained with mycophenolav, mofetil but the available reports are still scanty and the follow ups are short. Cyclosporine has been largely used both in controlled and non controlled trials with favorable results. However, being the drug nephrotoxic caution should be recommended with its use. Plasma-exchange and lipopheresis may attempted in resistant cases.

Original languageEnglish
Pages (from-to)345-348
Number of pages4
JournalClinical Nephrology
Volume55
Issue number5
Publication statusPublished - 2001

Fingerprint

Sclerosis
Focal Segmental Glomerulosclerosis
Plasma Exchange
Cytotoxins
Proteinuria
Pharmaceutical Preparations
Cyclosporine
Adrenal Cortex Hormones
Therapeutics

Keywords

  • Corticosteroids
  • Cyclosporine
  • Cytotoxic agents
  • Focal glomerulosclerosis

ASJC Scopus subject areas

  • Nephrology

Cite this

Ponticelli, C., & Passerini, P. (2001). Alternative treatments for focal and segmental glomerular sclerosis. Clinical Nephrology, 55(5), 345-348.

Alternative treatments for focal and segmental glomerular sclerosis. / Ponticelli, C.; Passerini, P.

In: Clinical Nephrology, Vol. 55, No. 5, 2001, p. 345-348.

Research output: Contribution to journalArticle

Ponticelli, C & Passerini, P 2001, 'Alternative treatments for focal and segmental glomerular sclerosis', Clinical Nephrology, vol. 55, no. 5, pp. 345-348.
Ponticelli, C. ; Passerini, P. / Alternative treatments for focal and segmental glomerular sclerosis. In: Clinical Nephrology. 2001 ; Vol. 55, No. 5. pp. 345-348.
@article{f340d0326f2a4f3c83bdb16f3d835410,
title = "Alternative treatments for focal and segmental glomerular sclerosis",
abstract = "Corticosteroids represent the first therapeutic approach for patients with focal and segmantal glomerulosclerosis. What to do in patients who do not respond to corticostetoids is still uncertain. Cytotoxic agents have been tried. The results are usually poor when these drugs are given for short periods but almost half of patients may enter remission ir treatment is prolonged. Some decrease in proteinuria may be obtained with mycophenolav, mofetil but the available reports are still scanty and the follow ups are short. Cyclosporine has been largely used both in controlled and non controlled trials with favorable results. However, being the drug nephrotoxic caution should be recommended with its use. Plasma-exchange and lipopheresis may attempted in resistant cases.",
keywords = "Corticosteroids, Cyclosporine, Cytotoxic agents, Focal glomerulosclerosis",
author = "C. Ponticelli and P. Passerini",
year = "2001",
language = "English",
volume = "55",
pages = "345--348",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "5",

}

TY - JOUR

T1 - Alternative treatments for focal and segmental glomerular sclerosis

AU - Ponticelli, C.

AU - Passerini, P.

PY - 2001

Y1 - 2001

N2 - Corticosteroids represent the first therapeutic approach for patients with focal and segmantal glomerulosclerosis. What to do in patients who do not respond to corticostetoids is still uncertain. Cytotoxic agents have been tried. The results are usually poor when these drugs are given for short periods but almost half of patients may enter remission ir treatment is prolonged. Some decrease in proteinuria may be obtained with mycophenolav, mofetil but the available reports are still scanty and the follow ups are short. Cyclosporine has been largely used both in controlled and non controlled trials with favorable results. However, being the drug nephrotoxic caution should be recommended with its use. Plasma-exchange and lipopheresis may attempted in resistant cases.

AB - Corticosteroids represent the first therapeutic approach for patients with focal and segmantal glomerulosclerosis. What to do in patients who do not respond to corticostetoids is still uncertain. Cytotoxic agents have been tried. The results are usually poor when these drugs are given for short periods but almost half of patients may enter remission ir treatment is prolonged. Some decrease in proteinuria may be obtained with mycophenolav, mofetil but the available reports are still scanty and the follow ups are short. Cyclosporine has been largely used both in controlled and non controlled trials with favorable results. However, being the drug nephrotoxic caution should be recommended with its use. Plasma-exchange and lipopheresis may attempted in resistant cases.

KW - Corticosteroids

KW - Cyclosporine

KW - Cytotoxic agents

KW - Focal glomerulosclerosis

UR - http://www.scopus.com/inward/record.url?scp=0035005011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035005011&partnerID=8YFLogxK

M3 - Article

C2 - 11393378

AN - SCOPUS:0035005011

VL - 55

SP - 345

EP - 348

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 5

ER -